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 INTRODUCTION 
Allergic or non-allergic non-infectious 
rhinitis is a common disease with a 
prevalence of 10–40 per cent (Malm-
berg 1979, Jones et al. 1998, Jessen 
and Janzon 1989, Sibbald and Rink 
1991). The upward trend in prevalence 
figures reported during the last few 
decades (Åberg 1989, Åberg et al. 
1995, Rimpelä et al. 1995) has been an 
incentive to extensive research on 
nasal allergy and hyperreactivity. The 
natural course of rhinitis has not been 
given much attention, however, and 
only a few reports have been pub-
lished. In these studies, individual 
symptom severity has shown a down-
ward trend with advancing age (Smith 
1971, Broder et al. 1974, Lehtonen and 
Haahtela 1988, Linna et al. 1992). 
Skin testing is the basic method of 
investigating patients with suspected 
nasal allergy. In selected cases, e.g. in 
suspected occupational rhinitis and in 
research set-ups, nasal allergen provo-
cation for verification of the skin test 
results may still be indicated. Barbee 
and co-workers (1987) have shown 
that skin-test results vary in the course 
of time, but it is unclear whether the 
variations occur concomitantly with 
changes in nasal symptom severity and 
nasal sensitivity to allergens. 
Extensive research work has been 
carried out on the physiology of 
olfaction and several methods have 
been utilized in assessing the sense of 
smell. Olfactory thresholds are known 
to be related to age. They are markedly 
higher among elderly people (Deems 
and Doty 1987), but in studies of 
rhinitis patients, the influence of age 
has usually been neglected. There are 
also a few studies in which quantitative 
assessment has shown deterioration in 
the sense of smell in patients with 
rhinitis (Cowart et al. 1993, Apter et 
al. 1995). 
The term nasal hyperreactivity is 
currently defined in two ways. Accord-
ing to Gerth van Wijk (1991), hyper-
reactivity in the airways refers only to 
an increased sensitivity to non-specific 
stimuli or irritants which do not act as 
allergens. In contrast, the German 
consensus statement (Bachert and 
Ganzer 1996) recognizes two cate-
gories of nasal hyperreactivity: spe-
cific, i.e. caused by allergens, and non-
specific, associated with non-specific 
stimuli. Nasal histamine provocation is 
one of many methods which have been 
used to assess the degree of nasal 
hyperreactivity. Attempts have been 
made to use this method as a test for 
differentiating a nose with non-specific 
hyperreactivity from a healthy nose in 
the same way as bronchial histamine 
provocation is used in the diagnostics 
of bronchial hyperreactivity (Sovijärvi 
et al. 1993). These efforts have pro-
duced contradictory results. Some 
investigators (Clement et al. 1985, 
Gerth van Wijk and Dieges 1987) have 
been able to discriminate allergic 
rhinitis patients from control subjects 
on the basis of histamine provocation, 
but often differences have not been 
demonstrable between various types of 
rhinitis patients or between rhinitis 
patients and control subjects (McLean 
et al. 1977, Guercio et al. 1979). 
Unlike bronchial challenge, nasal 
histamine provocation has appeared to 
be unsuitable for routine clinical 
practice because of considerable over-
lapping between patients and controls, 
but it has been used with some success 
as a research tool in selected set-ups. 
This study was carried out in order 
to investigate various aspects of the 
course of allergic and non-allergic 
hypersensitive rhinitis over a follow-up 
period of more than 20 years. 
 REVIEW OF THE LITERATURE 
Classification and 
definition of rhinitis 
The terms denoting various types of 
rhinitis have changed in the course of 
time. Earlier virtually all non-
infectious types of rhinitis were called 
”allergic”. In his authoritative textbook 
on nasal allergy in the late 70’s, 
Mygind (1979) divided rhinitis into 
three main classes, viz., hay fever, 
perennial rhinitis and nasal polyposis. 
Perennial rhinitis was further classified 
into allergic, non-allergic eosinophilic 
(intrinsic) and non-allergic non-eosino-
philic (autonomic) groups. In 1994, an 
international working group defined 
rhinitis as an ”inflammation of the 
lining of the nose, characterised by one 
or more of the following symptoms: 
nasal congestion, rhinorrhoea, sneezing 
and itching”. Their consensus report 
classified rhinitis into three main types: 
allergic (seasonal or perennial), infec-
tious (acute or chronic) and ”other”, 
which includes idiopathic rhinitis, non-
allergic rhinitis with eosinophilia 
syndrome, nasal polyps, occupational 
rhinitis, hormonal rhinitis, drug-
induced rhinitis, primary atrophic 
rhinitis and rhinitis produced by food 
or emotional factors (International 
Rhinitis Management Working Group 
1994). This classification was also 
mainly followed by Mygind and co-
workers (1996b) in their latest 
textbook. In a recent German con-
sensus statement on allergic rhinitis 
and its differential diagnosis (Bachert 
and Ganzer 1996), the term hyper-
reactivity (”Hyperreaktivität”) was 
used instead of rhinitis. Nasal hyper-
reactivity was divided into allergic 
(seasonal, perennial, occupational or 
nutritional), drug-induced, neurogenic, 
toxic, postinfectious or idiopathic. In 
addition, hyperreactivity of unknown 
origin was recognized as a separate 
entity. 
Natural course of rhinitis 
Few data are available on the natural 
course of non-infectious rhinitis. 
Some reports from the 60’s and 
70’s describe the results of question-
naire studies in children or young 
adults. In a study of 638 high school 
students (Freeman and Johnson 1964), 
improvement or regression of seasonal 
rhinitis had occurred after the age of 10 
years in 40% of the students with onset 
of hay fever in early childhood and in 
29% of those who had their first symp-
toms in adolescence. Of the adoles-
cent-onset group, one fourth reported 
that symptoms had increased since 
onset but this seldom occurred in the 
early-onset group. Yet, hay fever dis-
appeared in only 7% and perennial 
rhinitis in 4% of students with these 
symptoms. Smith (1971) found that 
8.9% of 112 farm children had been 
completely cured and 28.6% had 
become better over a period of five 
years. Hagy and Settipane (1976) 
followed 903 college freshmen for 
seven years after entering college and 
found hay fever as a new disease in 
12.6%, perennial rhinitis in 4.8% and 
asthma in 2.5% of the students, the 
annual incidences being 1.8%, 0.7% 
and 0.35%, respectively.  
A whole community (Tecumseh, 
USA) was studied by Broder and co-
workers (1974) in two surveys four 
years apart. Their diagnostic criterion 
of probable allergic rhinitis was report 
of hay fever, sinus trouble or persistent 
nasal symptoms together with two of 
the following: (1) itching of eyes, nose 
or throat, or burning, watering or 
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redness of eyes; (2) association of 
symptoms with exposure to aller-
gen(s); or (3) diagnosis of hay fever or 
allergic rhinitis by physician. The 
incidence in the residents of Tecumseh 
during this time was 2% and the preva-
lence 8.7%. Remission had occurred, 
i.e. allergic rhinitis had been absent for 
two or more years, in 5% of female 
and in 10% of male subjects. 
Rawle and co-workers (1983) fol-
lowed patients with asthma or hay 
fever for 10 to 40 years and reported a 
decrease in severe asthmatic symptoms 
and a progressive loss in serum anti-
bodies to Dermatophagoides ptero-
nyssinus but found no apparent 
tendency for skin test reactivity to 
decline with time. In a Finnish study of 
rhinitis patients without asthma, 
Lehtonen and Haahtela (1988) noted 
that hypersensitive rhinitis showed 
complete remission in 2%, was less 
severe in 54%, equally severe in 26% 
and more severe in 18% of subjects at 
follow-up after seven years. The 
prognosis of allergic rhinitis in patients 
with at least two positive skin tests was 
better than the prognosis of non-
allergic rhinitis. Symptoms had dis-
appeared or become less severe in 62% 
of allergic patients, but only in 46% of 
patients with non-allergic eosinophilic 
rhinitis and in 42% of those with non-
allergic non-eosinophilic rhinitis. 
Another Finnish study (Linna et al. 
1992) showed that symptoms had dis-
appeared completely over a period of 
9.5 years in 10% of 154 children with 
allergic rhinitis, diagnosed with skin 
tests and in questionable cases with 
conjunctival or nasal provocation. 
A comprehensive questionnaire 
study of 9,946 households with a total 
of 22,285 persons was recently 
published by Nathan and co-workers 
(1997). In this study, the frequency of 
self-diagnosed rhinitis (”seasonal 
allergy” or ”allergy all the time”) was 
14.2% (seasonal 8.8%, perennial 
5.4%), being highest (18%) between 
the ages of 18–49 years and decreasing 
gradually after the age of 50 years to 
8% in subjects over 65 years. 
Sense of smell in rhinitis 
The sense of smell is essential to our 
appreciation of the flavour and tasti-
ness of food and, more importantly, to 
detection of the smell of burning, 
dangerous vapours and spoiled food. 
The proportion of subjects with smell 
disorders is not well defined. An 
American questionnaire study revealed 
that 66% of over 1200 respondents 
were aware of a period in their life 
when smell acuity was decreased and 
seven per cent reported that their sense 
of smell was impaired at the time the 
survey was taken (Henkin 1995). The 
olfactory threshold is known to be 
markedly higher among elderly people 
(Deems and Doty 1987). Besides age, 
more than 200 diseases and other 
conditions (Leopold 1993) have been 
associated with changes in the chemi-
cal senses. The most frequent causes of 
olfactory loss are obstructive nasal and 
sinus diseases, which comprise 15–
33% of cases, upper respiratory infec-
tions (15–32%) and head trauma (9–
18%) (Deems et al. 1991, Leopold 
1993). Evidence of a direct relation-
ship between nasal resistance to air-
flow and olfactory threshold has not 
been presented (Eccles et al. 1989, 
Cowart et al. 1993). 
Apter and co-workers (1995) 
examined 227 patients with a history 
of olfactory loss, 116 (51%) of whom 
suffered from chronic rhinitis. In 
addition, skin tests were performed on 
62 patients with chronic rhinitis and 
olfactory loss without any neurological 
aetiology. At least one positive test 
was recorded in 44 (71%) subjects. 
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There are comparatively few 
studies in which the sense of smell of 
rhinitis patients has been measured. 
Seiden and co-workers (1989) evalu-
ated 34 patients with allergic rhinitis. 
Twenty of them (59%) reported that 
they had experienced some taste or 
smell problem and 12 patients (35%) 
had a measurable smell loss, as 
measured by the smell identification 
test. Cowart and co-workers (1993) 
measured the olfactory thresholds of 
91 patients with symptoms of allergic 
rhinitis and 80 non-atopic control 
subjects and found that the thresholds 
were significantly higher in allergic 
patients than in control subjects, with 
23.1% of the patients demonstrating a 
clinically significant loss of smell. 
In studies of rhinitis patients, the 
influence of age has usually been 
neglected. 
Skin tests in rhinitis 
patients 
Skin-test reactivity to allergens is the 
classic method to verify a diagnosis of 
allergic rhinitis and other allergic 
diseases (Mygind et al. 1996a). 
Allergy skin testing may be performed 
as a prick test, which consists of 
placing a drop of test solution on the 
skin and pricking through the drop 
with a sharp instrument, or as an 
intracutaneous (intradermal) test, in 
which a small amount of test solution 
is injected into the skin (Malling 
1993). According to the position state-
ment of the American Academy of 
Allergy and Immunology, prick testing 
is preferred for initial testing, because 
it is less expensive, quicker, causes 
less discomfort and correlates better 
with clinical sensitivity than does 
intracutaneous testing (Position state-
ment 1993). Also scratch tests were 
used in the past, but, according to the 
position paper of the European 
Academy of Allergology and Clinical 
Immunology, they are no longer 
recommended because of low speci-
ficity (Malling 1993). 
The epidemiology of skin-test 
results as compared with clinical 
disease has been thoroughly studied by 
Hagy and Settipane (1969). They 
interviewed a cohort of college fresh-
men on history of allergy among the 
subjects, their siblings, parents and 
grandparents. The frequency of hay 
fever was 21.1% and of non-seasonal 
rhinitis 5.2%. Skin scratch tests were 
performed with 15 allergens, including 
pollens, danders and moulds. The 
frequency of at least one positive skin-
test reaction was 63.8% in the group 
with asthma, hay fever or non-seasonal 
rhinitis. In their follow-up study seven 
years later (1976), they found a 
significant association between onset 
of allergic rhinitis as a new disease and 
a positive prior skin-test reaction. Of 
asymptomatic students with a positive 
pollen scratch test, 31.9% developed 
clinical hay fever during the follow-up 
period, whereas the corresponding 
percentage was only 7.7 for those with 
negative skin tests. For non-seasonal 
rhinitis, the proportions were 8.6% and 
3.2%, respectively. Since the skin tests 
were not repeated at the end of the 
follow-up period, it was not possible to 
determine, how many individuals with 
negative skin tests as freshmen may 
have developed positive reactions to 
allergens during the subsequent seven 
years. 
It is well known that ageing is 
associated with a decrease in the 
occurrence and intensity of skin 
reactions to common allergens. In a 
cohort study with repeated evaluations, 
Barbee and co-workers (1976, 1987) 
found an overall increase in skin-test 
reactivity during the eight-year period 
between two tests, the peak prevalence 
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occurring between ages 25 and 34, but 
at both evaluations there was a 
downward reactivity trend from this 
age group towards older age. The 
decrease in reactivity is thought to be 
caused by a reduction of IgE synthesis 
and a decrease in the skin capacity to 
respond to an immunological challenge 
(Delespesse et al. 1977). This phenom-
enon can be accounted for by relating 
the allergen test to the histamine 
control test (Mygind et al. 1996a). 
Nasal provocation 
In a nasal provocation test (nasal 
challenge) the nasal mucosa is exposed 
to allergens or irritant agents and the 
subsequent reaction monitored. Provo-
cation is a useful tool in research work 
and in cases where a verified allergy 
diagnosis is needed (Albegger 1991). 
In clinical work, the majority of provo-
cation tests are done with allergens. 
Nasal challenge is also used to assess 
non-specific nasal reactivity and reac-
tions have been induced with a variety 
of chemical substances and also with 
physical stimuli. 
Application methods 
There are several techniques of 
introducing the test substance into the 
nose. Soluble agents can be dropped 
(Bachert and Keilmann 1988, Mullins 
et al. 1989), sprayed (Pipkorn 1982, 
Yaniv et al. 1991, Hallen and Juto 
1992, Majchel et al. 1992) or 
nebulized into the nose (McLean et al. 
1977, Van de Heyning et al. 1989, 
Braunstein et al. 1992) or the nasal 
cavity washed with the test solution 
(Greiff et al. 1990). Challenge by 
topical application can be done with 
paper disks (Okuda 1977, Svensson et 
al. 1981, Ogino et al. 1992) or small 
swabs of cotton wool (Grobler et al. 
1966, Holopainen et al. 1976), 
impregnated with the challenge sub-
stance (Naclerio and Baroody 1992), 
or whole pollen grains delivered in the 
form of dry powder (Naclerio et al. 
1983). Gaseous agents can be deliv-
ered into the nose with any system that 
conveys gases into the airways 
(Andersson et al. 1995). For topical 
application, inferior turbinate and 
agger nasi are more sensitive locations 
than nasal septum or middle turbinate 
(Okuda 1977). Allergens in liquid form 
are often preferred to powder because 
of the lower risk of complications 
(such as asthmatic reaction or ana-
phylactic shock). Topical application 
limits the antigen contact to a very 
small area of the mucosa, which should 
lower the risk of complications (Holo-
painen et al. 1976). However, it is 
possible that paper disks themselves 
induce mucosal exudative inflamma-
tion (Andersson et al. 1995). None of 
the above methods can be regarded as 
absolutely superior, though theoretical-
ly the technique with minimum non-
specific effects should be the method 
of choice. 
Many investigators prefer unilateral 
provocation (Pipkorn 1982, Corrado et 
al. 1986, Doyle et al. 1990) while 
others use bilateral challenge (Okuda 
1977, Clement et al. 1985, Gerth van 
Wijk and Dieges 1991). Van de 
Heyning and co-workers (1989) 
recommend that both nasal cavities be 
challenged and the most reactive side 
considered, while Bachert and co-
workers (1990) and Albegger (1991) 
favour unilateral challenge on the 
wider side. 
Registration of the nasal response 
The provocation response has tradi-
tionally been assessed by observation 
of sneezing, nasal discharge and muco-
sal swelling by rhinoscopy (Pipkorn 
1982, Albegger 1991). Mygind and co-
workers (1986) recommend recording 
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the subject’s sensation of nasal secre-
tion, itching and congestion on a 
semiquantitative categorical score or a 
visual analogue scale. Counting the 
sneezes is a simple method to assess 
the irritative response (Pipkorn 1982, 
Gerth van Wijk and Dieges 1987). 
Another simple method is to measure 
the volume of elicited secretion, col-
lected by letting it drip into a funnel 
(Corrado et al. 1986, Gerth van Wijk 
and Dieges 1987) or by suction (Pirilä 
and Nuutinen 1998). Doyle and co-
workers (1990) weighed the subject’s 
handkerchiefs before challenge and 
after nose blowings after challenge. 
Naclerio and Baroody (1992) absorbed 
secretion into preweighed paper disks 
and reweighed them after a preset 
period of time. The difference in 
weights reflected the amount of secre-
tion collected in a fixed period of time. 
Rhinomanometry is widely ac-
cepted as an accurate objective method 
to register the challenge response by 
measuring changes in nasal airway 
resistance (NAR) (Corrado et al. 1986, 
Doyle et al. 1990). The most physio-
logical and currently most commonly 
used rhinomanometric technique is 
active anterior rhinomanometry 
(Clement 1984), where, simultaneously 
with measuring the air flow through 
one nostril with a pneumotachometer, 
the nasopharyngeal pressure is 
recorded contralaterally with a 
manometer which is connected to the 
other nostril. In posterior rhino-
manometry, the nasal flow is measured 
through a mask placed over the nose 
and nasopharyngeal pressure deter-
mined with a tube held between the 
lips and over the tongue (Goode 1986). 
A major disadvantage of the method is 
that only 50–80% of people tolerate 
the tube in the mouth and can relax the 
soft palate to maintain an open connec-
tion between the oral cavity and the 
nose while a nasal mask is applied 
(Kortekangas 1972, Masing 1979, 
Gleeson et al. 1986, Schumacher 
1989). 
In the Broms system for numerical 
description, the increase in nasal 
resistance is expressed as degrees of 
angle (Broms et al. 1982, Pipkorn 
1982). More often, the resistance is 
calculated at a fixed pressure gradient, 
usually at 150 Pascal, which is the 
recommendation of the International 
Standardization Committee for 
Rhinomanometry (Clement 1984). The 
increase in nasal resistance is regis-
tered as the difference between values 
at various steps of the provocation 
(McLean et al. 1977, Clement et al. 
1985, Gerth van Wijk and Dieges 
1987, Mullins et al. 1989, Van de 
Heyning et al. 1989). Stable conditions 
during the course of the provocation 
are a sine qua non for successful use of 
rhinomanometry. Especially critical 
are a correct fitting of the face mask 
without any distortion of the nose, 
tightness of all seams between the 
different parts of the rhinomanometer 
and between the equipment and the 
patient (Pinkpank 1986). 
Nasal peak expiratory and inspira-
tory flow measurements have also been 
used to register changes in nasal 
patency to measure nasal obstruction 
following challenge (Haahtela 1978, 
Schumacher and Pain 1979, Wihl and 
Malm 1988, Holmström et al. 1990, 
Hellgren et al. 1997, Phagoo et al. 
1997). In the last 20 years, acoustic 
rhinometry (Hellgren et al. 1997, 
Zweiman et al. 1997) and rhino-
stereometry (Juto and Lundberg 1982) 
have been introduced as sophisticated 
novel methods for measuring mucosal 
swelling. 
Nasal histamine provocation 
Application of histamine into the 
nose induces a sneezing reflex, a 
secretory response and mucosal 
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swelling, resulting in an increase in 
NAR (Grobler et al. 1966, Gerth van 
Wijk and Dieges 1987). Both 
histamine phosphate (Grobler et al. 
1966) and histamine chloride (Okuda 
1977) have been used as the challenge 
agent. Often, however, only ”hista-
mine” is mentioned in a report. 
A simple classification of the 
challenge result as either negative or 
positive is seldom meaningful for 
histamine reactions, though sufficient 
for allergen challenge. It is more 
sensible to assess the intensity of the 
reaction at various steps. If rhino-
manometry is chosen as the method of 
assessment, the dose or concentration 
required to induce an increase of 25% 
(PD25 or PC25), 50% (PD50 or PC50) or 
100% (PD100 or PC100) in NAR can be 
determined (McLean et al. 1977, 
Clement et al. 1985, Gerth van Wijk 
and Dieges 1987, Mullins et al. 1989, 
Van de Heyning et al. 1989). 
At present there is no standard 
procedure for nasal histamine provo-
cation but a certain method is used in 
one or a few centres only and the 
results of different studies are poorly 
comparable. 
Numerous attempts have been 
made to prove the hypothesis that 
rhinitis patients are more sensitive to 
histamine than healthy subjects and to 
develop a method which would 
identify rhinitis subjects. One of the 
first attempts was made in 1966 by 
Grobler and co-workers, who showed 
that responsiveness to nasal histamine 
was related to the degree of nasal 
complaints in patients with chronic 
bronchitis. Okuda and co-workers 
(1983) used only sneezing as a 
criterion and defined the end point as 
the minimum concentration of hista-
mine which produced sneezes within 
one minute. They recorded a difference 
in the sensitivity between the normal 
and the allergic nose and also between 
an allergic nose with positive 
provocation and a nose with negative 
provocation. Clement and co-workers 
(1985) found a ”slightly significant” 
difference in nasal histamine 
thresholds between patients with non-
allergic rhinitis and controls, as 
assessed by changes in NAR at a flow 
of 0.25 l/s. Corrado and co-workers 
(1986) reported that subjects with 
perennial allergic rhinitis showed 
significantly greater histamine-induced 
changes in NAR, rhinorrhoea and also 
methacholine-induced rhinorrhoea than 
subjects without rhinitis. Using a 
doubling of nasal resistance as a 
criterion, Mullins and co-workers 
(1989) found that the histamine doses 
required to induce this response were 
lower among patients with perennial or 
seasonal allergic rhinitis than among 
control subjects. Van de Heyning and 
co-workers (1989) were able to 
differentiate between patients with 
non-allergic rhinitis and healthy 
control subjects by determining PD25, 
PD50 and PD100. In their opinion, 
determination of PD25 was the most 
valuable clinical test in unilateral 
provocation, but, according to Gerth 
van Wijk and Dieges (1987) on the 
other hand, measurement of NAR 
proved insensitive, while assessment of 
nasal secretion and sneezing was a 
sensitive method for discrimination 
between rhinitis patients and controls. 
Often, however, considerable over-
lapping has been demonstrated in 
reactivity between rhinitis patients and 
healthy controls, which clearly thwarts 
the discriminating potency of the 
method (McLean et al. 1977, Guercio 
et al. 1979, Gerth van Wijk and Dieges 
1991). 
Thus, results are contradictory and 
nasal histamine provocation is not 
recommended for routine diagnostics. 
As a research tool, histamine provo-
cation has been successfully used in 
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the evaluation of drug therapy (Pipkorn 
1982, Baroody et al. 1992, Ogino et al. 
1992) as well as rhinitis group 
comparisons, as described above. 
The causes underlying nasal 
hyperreactivity are not fully 
understood. Earlier, many researchers 
supported the assumption that mucosal 
permeability is enhanced in allergic 
rhinitis (Salvaggio et al. 1964, Inagaki 
et al. 1985, Gerth van Wijk and Dieges 
1987) but later studies have 
demonstrated decreased mucosal 
absorption in patients with rhinitis 
(Greiff et al. 1993, Greiff et al. 1997). 
Other potential explanations for nasal 
hyperresponsiveness have also been 
suggested, including changes in 
responsiveness at receptor level, neural 
hyperfunction and effector end-organ 
hyperresponsiveness (Andersson and 
Mygind 1995). 
Nasal allergen provocation 
Skin testing does not necessarily give 
relevant information on the sensitivity 
of the airways to allergen. Earlier when 
the quality of allergen extracts was 
poorer than it is today, irritants 
frequently caused false positive skin 
reactions (Mygind et al. 1996a). Nasal 
allergen provocation was, therefore, 
used to obtain more reliable informa-
tion on the specificity of nasal allergy. 
Modern preparations are better in this 
respect. Petersson and co-workers 
(1986) reported good agreement be-
tween the results of skin prick tests and 
nasal or conjunctival provocation tests 
for birch and timothy allergens. For 
skin prick tests and clinical history, the 
agreement was somewhat poorer. The 
positive predictive value of the skin 
prick test as compared with the 
provocation test was 95% and the 
negative predictive value 97% for 
birch allergen, with a frequency of 
55%. For timothy allergen, the 
predictive values were 78% and 96% 
and the frequency 52%. The frequen-
cies of positive findings in their patient 
groups were higher than the prevalence 
of allergic rhinitis in the population 
(Malmberg 1979, Varjonen et al. 1992, 
Norrman et al. 1994), which implies 
that in representative samples of the 
population the positive predictive 
values would be smaller (Altman 
1994a). 
Standardized extracts are not 
always available, especially in the case 
of rare allergens. In these situations 
and also when definite causality 
between allergen exposure and nasal 
disease must be verified, nasal allergen 
provocation is still necessary in 
rhinological diagnostics (Melillo et al. 
1997). The most important indications 
are discrepancy between patient 
history and allergy tests, verification of 
nasal allergy prior to starting immuno-
therapy, and diagnosis of occupational 
rhinitis. The fact that the test is time-
consuming also makes it less suitable 
for routine diagnostics. 
In allergen provocation, the nasal 
mucosa is exposed to allergen in 
controlled conditions which try to 
mimic natural exposure. If allergic 
symptoms appear, a causal relation is 
very likely. 
There are several criteria for 
positivity of the challenge. Holopainen 
and co-workers (1976) considered the 
reaction positive when two of the 
following responses were observed: 
sneezing, itching, secretion or subjec-
tively noted obstruction of the nose, a 
change in the colour of the mucous 
membrane, swelling of the turbinates 
noted by rhinoscopy, or an increase of 
25% or more in total nasal resistance 
(TNR) measured by posterior rhino-
manometry. Okuda (1977) regarded 
sneezing, definitive nasal secretion or 
swelling of the nasal mucous mem-
brane as a positive response and used a 
3-grade scale, according to the number 
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of symptoms and the number of 
sneezes, for further assessment of the 
reaction. Central European recommen-
dations (Bachert et al. 1990, Albegger 
1991) suggest either an increase of 
60% in nasal resistance or a decrease 
of 40% in nasal airflow, measured by 
rhinomanometry, or more than three 
points on a combined score of nasal 
discharge (0–2 points), sneezing (0–2 
points) and remote symptoms, i.e. 
tearing, pharyngeal swelling, ear 
blocking, conjunctival redness, 
urticaria, cough, and dyspnoea, (0–2 
points) as alternative criteria of 
positivity. In patients with suspected 
occupational rhinitis, Hytönen and Sala 
(1996) used four-point scales of 
rhinoscopically evaluated nasal block-
age and rhinorrhoea and regarded the 
provocation as positive, if the change 
in the total score was four points or 
more. 
Sipilä and co-workers (1990) com-
pared the changes in unilateral nasal 
resistance caused by the nasal cycle 
with those elicited by allergen chal-
lenge and recommended that if results 
of nasal provocation are expressed by 
rhinomanometry, at least a doubling or 
an even higher increase in the 
resistance must occur before the result 
is considered positive. Pirilä and co-
workers (1997) monitored the nasal 
patency of 12 subjects with suspected 
occupational allergic rhinitis at 15-
minute intervals for 3 hours before and 
for 30 minutes after nasal challenge 
with diluent. They found a high degree 
of spontaneous variation in NAR, 
which increased with longer obser-
vation time. According to their results, 
a unilateral increase of 100 per cent 
could be used as a cut-off value at the 
risk level of 5–10 per cent, when the 
observation period after the provo-
cation was 30–60 minutes. They 
further recommended that resistance 
changes should be interpreted with 
caution and that other objective means 
should be used in addition. 
Acoustic rhinometry has only 
recently been introduced in the 
evaluation of allergen provocation. 
Lane and co-workers (1996) monitored 
the minimum cross-sectional area and 
the nasal cavity volume of the first 7.5 
cm from the nasal vestibule. Nasal 
allergen challenge induced a mean 
reduction of 70% in minimum cross-
sectional area and of 58% in nasal 
volume. Hytönen and co-workers 
(1996) registered changes in nasal 
mucosal swelling during allergen 
challenge with acoustic rhinometry and 
concluded that changes in the volume 
or minimum cross-sectional area of the 
nasal cavity, measured separately in 
the anterior and middle parts, were less 
usable in the diagnostics of occu-
pational rhinitis than a combined 
variable, calculated as the mean of the 
percentages expressing the changes in 
the volume and area variables. Their 
recommendation for the limit of an 
essential change was a decrease of 
15% or more in the combined variable. 
Other agents used for nasal 
provocation 
Methacholine is a cholinergically 
acting compound, which induces a 
secretory response in nasal mucosal 
glands. Both methacholine bromide 
(Borum and Mygind 1979) and metha-
choline chloride (Malmberg et al. 
1983) have been used as provocation 
agents to measure nasal hyper-
reactivity. In comparison with hista-
mine phosphate, methacholine and also 
phentolamine seem to be less sensitive 
agents for discriminating between 
healthy subjects and rhinitis patients 
(Gerth van Wijk and Dieges 1987). 
Other substances that have been 
employed in challenge measurements 
of nasal hyperreactivity are polymyxin 
B, ammonia (McLean et al. 1978), 
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platelet activating factor (PAF) 
(Klementsson and Andersson 1992) 
and substance P (Devillier et al. 1988). 
Nasal reactions to physical stimuli, 
especially to cold dry air, have also 
been studied (Togias et al. 1988). 
Measurement of 
olfaction 
The simplest form of testing the sense 
of smell is to determine whether the 
subject can detect any odorant at all. 
This type of testing is not very precise 
and is unsatisfying in diagnostics. 
Good clinical practice requires quanti-
tative, repeatable tests for objective 
documentation of olfactory ability. The 
two aspects that are most commonly 
tested are olfactory threshold and 
identification ability. 
The measurement of the detection 
threshold attempts to quantify the most 
diluted concentration of an odorant that 
a subject can detect. Earlier, this was 
done by diluting odorous gas with air, 
or liquid odorant with alcohol or 
odourless diluent, and measuring the 
weakest dilution the subject could 
detect. The modern general format of 
this test is to use a series of bottles 
containing a range of concentrations in 
predetermined steps. The odorant is 
presented from lowest to highest 
concentration until the subject 
correctly identifies it. In order to avoid 
the tendency of the subject to say ”yes” 
to undetectable stimuli, a similar bottle 
containing only the diluent is presented 
simultaneously and the subject is 
forced to choose between a stimulus 
and a blank (Amoore and Ollman 
1983, Amoore and O'Neill 1986, Cain 
1989). Pyridine and n-butyl alcohol are 
two of the most widely used test 
chemicals, but phenyl ethyl alcohol 
(Doty et al. 1978) and phenylethyl 
methyl ethyl carbinol (Rosen et al. 
1979) have been recommended 
because they have less trigeminal 
activity. Machine-assisted measure-
ments of olfactory function are not 
usually practised in clinical work. 
Investigative work has been done on 
olfactory-evoked potentials using 
electroencephalographic techniques or 
on positron emission tomography 
scanning of the olfactory cortex 
(Henkin 1995). 
Odour quality identification is the 
basis of the most commonly used 
procedures for clinical assessment of 
ability to smell. The subject can be 
asked to name each of a set of odours 
(odour naming test), to indicate 
whether or not an odour smells like a 
certain fragrance (yes–no odour 
identification test) or to recognize the 
odour from a list (multiple-choice 
odour identification test) (Doty 1991). 
In clinical work, the most popular type 
is the multiple-choice test (Wright 
1987, Cain et al. 1988). The UPSIT 
test (University of Pennsylvania Smell 
Identification Test) designed by Doty 
and co-workers (1984) is particularly 
compact and widely used. The test 
comprises booklets, each page of 
which has an area with the smell 
encapsulated in small crystals. The 
smell is released by scratching the 
odorous area. The disadvantage of this 
test is that it contains some odours that 
are not universally familiar. To solve 
this problem, Doty and co-workers 
(1996) developed a 12-item cross-
cultural smell identification test. 
Both threshold and identification 
tests are useful in clinical diagnostics 
of disorders of the sense of smell. 
Some authors prefer using either one 
of the methods, while others recom-
mend that both types of measurements 
be used (Moore-Gillon 1989). Some 
centres use a composite score of the 
two methods (Cain 1989). Both 
techniques are considered good 
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indicators of the sensitivity of the 
sense of smell, and the correlation 
between the tests is good (Cain et al. 
1988). 
 PURPOSE OF THE STUDY 
The aims of this study were 
 
 
1. to describe the changes in symptom 
severity that had occurred in a series 
of patients with allergic or non-
allergic rhinitis over a period of 
nearly 20 years; 
2. to analyse skin-test sensitivity 
some 20 years after primary testing 
and to relate possible changes in 
reactivity to ageing, duration of 
rhinitis, and changes in severity of 
rhinitis symptoms; 
3. to measure and compare olfactory 
thresholds in rhinitis patients and 
healthy control subjects and to 
analyse possible relationships 
between the sense of smell and 
rhinitis, age, gender, smoking, 
prick-test results, nasal resistance, 
and history of nasal or paranasal 
surgery; and 
4. to measure nasal reactivity to 
histamine in patients with long-
continuing allergic rhinitis and to 
assess whether the degree of nasal 
hyperreactivity corresponded with 
changes in allergy test results and 
in rhinitis symptom severity. 
 SUBJECTS AND METHODS 
Definitions 
The terms used for rhinitis forms 
discussed in this thesis were defined as 
follows: 
Allergic or atopic rhinitis refers to 
the form of rhinitis that occurs as a 
consequence of the IgE-dependent 
activation of mast cells in the nasal 
mucosa, i.e. represents the type I 
reaction of the classification by 
Coombs and Gell (Mygind 1979). 
The term non-allergic rhinitis 
denotes a chronic disease of the nasal 
mucosa which by current investigation 
methods cannot be related to allergy, 
infection, structural lesions or other 
known aetiology (Mygind et al. 
1996b). 
The term hypersensitive rhinitis or 
nasal hyperreactivity is used as a 
comprehensive concept for both 
allergic and non-allergic rhinitis 
(Bachert and Ganzer 1996). 
Patients 
This follow-up study was carried out in 
patients with allergic or non-allergic 
rhinitis at the Department of Otorhino-
laryngology, Helsinki University 
Central Hospital, and covers a period 
of 18 to 25 years. The patients were 
initially examined in 1969-72 when 
patients remitted to the Department 
with a clinical diagnosis of allergic 
rhinitis were enrolled in a study and 
underwent a fixed set of investigations 
including clinical examination of the 
nose by anterior and posterior rhino-
scopy, exfoliative nasal cytology, 
bacteriological culture of the nasal 
secretion, allergy tests, X-ray 
examination of sinuses and teeth, and 
blood tests for haemoglobin, eosino-
phil count, antistaphylolysin and anti-
streptolysin titres. A diagnosis of 
allergic or non-allergic (intrinsic) 
rhinitis was then established in 770 
patients (Binder et al. 1982, Binder et 
al. 1984). If needed, operations for 
structural deformities of the nose and 
chronic sinusitis were performed. 
Four follow-up studies were per-
formed in a group of patients from the 
original series in 1989–94. The group 
was the same in all studies, but the size 
of the group varied from 180 patients 
in study I to 73 patients in study IV. 
Study I was a questionnaire study 
in all patients of the original series who 
could be located in 1989. Of 261 
contacted subjects, 186 filled out the 
questionnaire and 180 were accepted 
for the study. Two forms were rejected 
because of missing identification and 
four because of conflicting and in-
adequate information. There were 108 
women and 72 men. Their mean age at 
the time of the initial study was 29 
years (range 3.6–69 years) and the time 
period between the initial study and the 
questionnaire was on average 18 years 
(range 17–20 years). 
Study II was an analysis of changes 
in rhinitis symptoms in relation to skin 
test reactivity and nasal sensitivity to 
allergens in 108 of the 180 patients in 
study I (61 women and 47 men, ages 
27–78 years, mean 51 years). The 
mean duration of follow-up was 23 
years (range 20–25 years). One patient 
withdrew at an early stage before 
allergy tests were performed and one 
patient was excluded because of no 
recordable reaction to any substance 
including the histamine control. 
Study III was an evaluation of the 
sense of smell in 105 of the 108 
patients, 61 women and 44 men, aged 
27 to 78 years, mean 51 years. In 
addition to the patient who withdrew 
Subjects and methods 
 
early, two patients who did not have 
time for further testing did not 
participate in the study. 
Study IV was performed in a 
subgroup of the 108 patients in studies 
II and III. The subgroup included all 
75 patients in whom the diagnosis of 
allergic rhinitis had been confirmed in 
1969–72. Apart from the patient who 
was not tested because of early 
withdrawal, one patient could not be 
provoked because of upper respiratory 
infection. The analyses were done in 
73 patients, 46 women and 27 men, 
aged 28 to 74 years, mean age 48 
years. 
Control subjects (study 
III) 
In order to compare the olfactory 
thresholds in rhinitis patients and 
subjects without nasal diseases, a 
control group was collected among 
patients with no acute or chronic nasal 
complaints, admitted to hospital for 
elective ear, palatine tonsil or neck 
surgery. The group consisted of 104 
subjects (56 women and 48 men, aged 
17–71 years, mean 39 years). 
Collection of anamnestic 
data 
Questionnaires were compiled for 
collecting data on the course of rhinitis 
and changes in symptom severity in 
studies I–III. 
The items on the questionnaire 
filled out by all 180 patients in study I 
are listed in Table 1. 
Prior to the first follow-up visit (II), 
all 108 patients completed a second 
questionnaire for more detailed 
information on past and present history 
(Table 2). 
In study III, a questionnaire was 
also used to collect information on 
possible past and present rhinitis 
symptoms, smoking habits and asthma-
like symptoms in the group of control 
subjects (Table 3). 
Table 1. Anamnestic data collected with the help of a questionnaire (I) in 1989 
Age at onset of rhinitis 
The first symptom of allergy (rhinitis, eczema or 
asthma) 
Occurrence of rhinitis symptoms (still/no longer 
occur) 
In case of remission: 
Age at the remission of rhinitis 
Factor(s) that caused the remission 
In case of continuing symptoms: 
Annual occurrence (seasonal, perennial) 
Factors associated with the symptoms (pollen of 
the trees, hay or mugwort; dust; animals, 
other) 
Changes in the annual period of the symptoms 
(shorter, unchanged, longer) 
Changes in severity of symptoms (milder, 
equally severe, worse) 
Occurrence of asthma (if yes, when and how 
diagnosed?) 
Occurrence of nasal polyps (if yes, when?) 
Operations performed because of nasal disorders 
(polypectomy, ethmoidectomy, septoplasty, 
sinus operation) 
Effect of the operation on symptoms of rhinitis 
and/or asthma 
Influence of analgetics on rhinitis symptoms 
Influence of smoking on rhinitis symptoms 
Influence of alcohol (beer, wine, liquor) on 
rhinitis symptoms 
Medication used for rhinitis 
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Table 2. Anamnestic data collected prior to the follow-up visit (II, III and IV) in 1993–94. The items 
that were not included in the earlier questionnaire are shown in italics. 
Occurrence of rhinitis symptoms (still/no longer 
occur) 
Changes in rhinitis symptoms (total remission, 
milder, unchanged, worse) a) after the first 
questionnaire study in 1989 and b) altogether 
after the first investigation in 1969–72 
In case of continuing symptoms: 
Annual occurrence (seasonal, perennial, 
combined) 
Months, when symptoms occur 
Occurrence of asthma 
Age at onset of asthmatic symptoms 
Diagnosis established: a) by physician, b) at 
hospital 
Entitled to special drug reimbursement 
Current symptoms of asthma 
Occurrence of nasal polyps 
If yes, when for the first time 
Operations for polyposis 
Medication for polyposis 
Medication for rhinitis 
Other medication 
Occurrence of occupational rhinitis 
Loss of the sense of smell 
Hoarseness (never, occasionally, in conjunction 
with rhinitis symptoms, constantly) 
Snoring (unknown, never, occasionally, often, 
constantly) 
Smoking (never, ex-smoker, 1–5, 6–10, 11–20, 
more than 20 cigarettes/day or equivalent 
amount of pipe tobacco) 
Nasal surgery 
 
Table 3. Anamnestic data collected with the help of a questionnaire from control subjects (study III) 
Occurrence of atopic eczema in childhood 
History of allergic symptoms (nasal obstruction or 
discharge, sneezing, cough, dyspnea, rash, eye 
symptoms) 
Age at onset of possible rhinitis 
Current rhinitis symptoms 
Current symptoms of respiratory infection 
Smoking (never, ex-smoker, 1–5, 6–10, 11–20, 
more than 20 cigarettes/day or equivalent 
amount of pipe tobacco) 
 
Ethics 
The study protocol was approved by 
the ethics committee of the Department 
of Otorhinolaryngology of Helsinki 
University Central Hospital. All 
subjects gave their informed consent 
with regard to participation in the 
study. 
Allergy tests in the initial 
study 
All patients had initially in 1969–1972 
undergone a fixed set of investigations 
including history taking, allergy testing 
with scratch or intracutaneous tests, 
nasal provocation, and otorhino-
laryngological examinations (Binder et 
al. 1982, Binder et al. 1984). The 
number of patients in the initial series 
was 770. 
The following allergens were 
included in the initial skin tests and the 
results were available for the follow-up 
analysis: birch (95 patients included in 
studies II and III), grass species 
(timothy or meadow foxtail, 95 
patients), Compositae species (dande-
lion, Chrysanthemum species, mug-
wort, 90 patients), house dust or house 
dust mite (95 patients), animal dander 
(horse, cow, dog, and cat, 83 patients), 
chicken feather (78 patients), wool (78 
patients), mould mix (76 patients), and 
food allergens (hazelnut, egg, fish, 
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cow’s milk, 45 patients). In grading the 
test results, a scale from ”-” to ”++++” 
was used, ”+” indicating a weal whose 
diameter was at least 25% of the 
diameter elicited by the positive 
histamine control, and ”++” indicating 
a weal with a diameter at least 50% of 
the positive control. The criterion for a 
positive skin test was a reaction greater 
than ”+”. Seventy-eight per cent of the 
patients showed at least one positive 
skin test result. 
The nasal provocation was 
considered positive when at least two 
of the following criteria were met after 
challenging the nose with allergen: 
itching, sneezing, discharge, subjec-
tively noted obstruction of the nose or 
a rhinoscopic finding of changes in the 
nasal mucosa (swelling or colour 
change) or an increase of 25 per cent 
or more in TNR as measured by active 
posterior rhinomanometry (Holopainen 
et al. 1976, Malmberg et al. 1978). The 
patient was considered allergic, if he or 
she had at least one positive skin test 
confirmed by positive nasal provo-
cation. Sixty-nine per cent of the 
patients fulfilled this criterion. 
Skin tests in the follow-
up study (II, III, IV) 
Skin prick tests were performed with 
Soluprick® allergen solutions (ALK, 
Denmark). All patients were tested 
with 22–26 common allergens, 
including birch, alder, meadow foxtail, 
orchard grass, meadow fescue, 
ryegrass, timothy, Kentucky bluegrass, 
mugwort, dandelion, horse, dog, cat, 
and cow dander, wool, chicken feather, 
Dermatophagoides farinae and 
pteronyssinus, Alternaria alternata, 
Candida albicans, Cladosporium 
herbarum, guinea pig, latex, egg, fish 
and cow’s milk. During the period of 
the follow-up visits, the standard test 
series of the clinic was extended to 
include latex, egg, fish and milk 
allergen, which were, therefore, tested 
only on 52 patients. The patient was 
considered prick-test positive, if at 
least one allergen elicited a weal 
whose diameter was at least 3 mm 
larger than that of the negative control. 
Nasal allergen 
provocation (studies II, 
IV) 
Nasal allergen provocation was 
performed on patients who had been 
diagnosed as allergic in the initial 
study or were prick-test positive or had 
a positive history of allergic symptoms 
possibly caused by some specific 
allergen. At the beginning of the 
session, anterior rhinoscopy was 
performed and the amount of mucus 
and degree of conchal swelling were 
recorded. The nose was first 
challenged with the diluent of the 
allergen extract (ALK-Diluent®, ALK, 
Denmark) and assessment was made 
after 15 minutes. After challenging 
with Aquagen® SQ (ALK, Denmark) 
aqueous allergen solution, the response 
was assessed after 15 and 30 minutes 
(and 45 minutes for house dust mite 
allergen) unless a positive reaction had 
been recorded earlier. The provocation 
was done bilaterally with a spray dose 
of 0.1 ml. In most cases, a concen-
tration of 100,000 SQ units per ml 
(SQ-U/ml) was used. In seven cases in 
which an exceptionally strong reaction 
was anticipated, 1000 SQ-U/ml was 
used first and, if needed (in four 
patients), a stronger solution later. 
Rhinorrhoea and conchal swelling 
were graded in each nasal cavity on a 
three-point scale (none – mild – 
considerable). The number of sneezes 
between the provocation and recording 
was counted. Other possible symptoms 
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or signs, i.e. tearing, pharyngeal 
swelling, ear blocking, conjunctival 
redness, urticaria, cough, and 
dyspnoea, were registered. 
In conjunction with all assess-
ments, nasal resistance was measured 
on each side at 150 Pa pressure and 
TNR calculated using a RhinoComp® 
computerized active anterior rhino-
manometer. The technique complied 
with the recommendations of the 
International Committee on 
Standardization of Rhinomanometry. 
The recorded changes were 
converted into a provocation result 
score as described in Table 4 (slightly 
modified after Albegger (1991)). The 
provocation was considered positive, if 
a score of at least 3 points was 
achieved or if the patient got 2 points, 
but TNR increased at least 50% 
compared with the measurement after 
the diluent challenge. 
Table 4. The score of nasal allergen provocation (II, IV) 
1. Average increase in nasal discharge 
none 0 points 
change from none to mild or mild to considerable on at least one side 1 point 
bilateral reaction, change from none to considerable on at least one side 2 points 
2. Average increase in swelling of the inferior turbinates 
none 0 points 
change from none to mild or mild to considerable on at least one side 1 point 
bilateral reaction, change from none to considerable on at least one side 2 points 
3. Irritation 
0–2 sneezes 0 points 
3–5 sneezes 1 point 
6 sneezes or more 2 points 
4. Remote symptoms 
tearing, pharyngeal swelling or ear blocking 1 point 
conjunctival redness, urticaria, cough or dyspnoea 2 points 
 
Nasal histamine 
provocation (study IV) 
Nasal hyperreactivity was measured by 
histamine provocation. Prior to hista-
mine challenge, a control challenge 
was performed bilaterally by spraying 
a 0.1 ml dose of phosphate buffer into 
the nostril. The nose was then washed 
with phosphate buffered saline and a 
nasal smear sample taken with a cotton 
swab. Histamine challenge was carried 
out stepwise with bilateral 0.1 ml doses 
of 0.025%, 0.1%, 0.4% and 1.6% 
histamine diphosphate solutions, di-
luted with phosphate buffer. As in 
allergen provocation, the degree of 
rhinorrhoea and conchal swelling was 
assessed and the number of sneezes 
counted after each provocation step, 
and NAR measured with active 
anterior rhinomanometry at the 
beginning of the session and after each 
of the challenge steps. The recordings 
before spraying the first histamine dose 
were used as baseline values. If 
rhinomanometric data could not be 
obtained because of total obstruction in 
the course of the histamine challenge, 
the last measured value multiplied by 
the ratio of the means of these two 
values for the whole series was used in 
the analyses. 
Nasal responsiveness to histamine 
was compared between the following 
subgroups of patients: 
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1.  prick-test positive versus prick-test 
negative patients 
2.  patients with positive nasal allergen 
provocation versus patients with 
negative provocation 
3.  patients with or without changes in 
rhinitis symptom severity, i.e. 
patients whose rhinitis symptoms 
had disappeared, become milder, 
remained equally severe or 
worsened during follow-up for 23 
years. 
 
The following variables were used in 
the analysis: 
 
1. The concentration which induced an 
average increase of at least one 
point in nasal secretion or at least 
five sneezes (slightly modified after 
Gerth van Wijk and Dieges (1987)). 
2. The sum of the irritation score, as 
defined in Table 4, and average 
discharge (scored none = 0, mild = 
1, considerable = 2 on each side) at 
each step. 
3. The sum of variable 2 and average 
swelling of the turbinates (scored 
none = 0, mild = 1, considerable = 2 
on each side) at each step. 




The olfactory threshold was measured 
with a commercially available smell 
test kit (Olfacto-Labs, Berkeley, Cali-
fornia) (Amoore and Ollman 1983, 
Amoore and O'Neill 1986). Sensitivity 
to odour was tested stepwise with 
phenylethyl methyl ethyl carbinol at 
3.2 concentrations in nine pairs of 
polypropylene squeeze bottles, the 
control bottle in each pair containing 
the plain diluent. The subject was 
asked to choose the bottle he or she 
thought contained the odorant and the 
test was repeated three times at each 
step. The weakest concentration at 
which the subject picked the correct 
bottle all three times was accepted as 
the olfactory threshold. Numerically, 
the threshold was expressed as 
arbitrary logarithmic units (ALU), 
designated as ”decismels” (dS) by the 
manufacturer, analogically with the 
audiological decibel scale. The 
concentrations in use were -25, -15, -5, 
5, 15, 25, 35, 45, and 55 ALU. In the 
statistical analyses, the value of 65 
ALU was used for those who could not 
identify the strongest concentration. To 
avoid the possible effect of recent 
smoking on the result, an interval of at 
least 15 minutes was required between 
smoking and testing. 
Statistics 
McNemar’s test was used to analyse 
paired dichotomous data. Differences 
between groups were tested using 
Student’s t test, the Mann–Whitney U 
test, Fisher’s exact test, Pearson’s Chi 
squared test, and the Chi squared test 
for trend. For analysis of variance, the 
non-parametric Kruskal–Wallis analy-
sis of variance, the parametric analysis 
of variance and analysis of variance for 
repeated measurements were used. 
Multiple comparisons were performed 
using the Scheffé test. Correlations 
were tested by calculating Pearson’s 
product moment correlation coef-
ficients or Spearman’s rank order 
correlation coefficients. Agreement 
between the results of the prick test 
and nasal allergen provocation was 
tested with kappa statistics (Altman 
1994b). 
In study III, stepwise multiple 
linear regression analysis was used to 
examine the associations between 
olfactory threshold and age, presence 
of rhinitis, gender, and smoking in all 
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subjects and between olfactory thresh-
old and age, diagnosed asthma, gender, 
ethmoidal and maxillary operations, 
prick-test positivity, nasal resistance, 
duration of rhinitis, actual rhinitis 
symptoms, and smoking in the patient 
group. The age-related 95% reference 
interval for the olfactory threshold was 
calculated using the method described 
by Isaacs and co-workers (1983). A 
linear regression model was first fitted 
to the data of the control group. 
Another linear regression model was 
fitted to the standard deviations of the 
residuals about the first regression. For 
this purpose, the age range was divided 
into five 10-year brackets: 15–25, 25–
35, 35–45, 45–55, and 55–65 years. In 
addition, the two persons aged over 65 
years were consolidated in the 55–65 
age group. The reference interval was 
calculated as  
f1(age) ± 1.96 × f2(age) 
where f1 and f2 are the functions of age 
fitted to the threshold data and the 
residuals, respectively. 
 RESULTS 
Patient history (studies I, 
II) 
According to the questionnaires (I) 
completed after a follow-up period of 
18 years, 131 of 180 subjects still had 
symptoms of rhinitis. Favourable 
changes were reported by 116 subjects 
(64%, 95% confidence interval (CI) 
57%–71%), i.e. symptoms had either 
disappeared or become milder. The 
details are shown in Table 5. 
Remission had occurred in 24 of 111 
(22%) in the group with initially 
confirmed nasal allergy and in 25 of 69 
(36%) in the non-allergic rhinitis 
group. The difference between the 
proportions was 0.15 (95% CI 0.01–
0.28, χ² = 4.58, P = 0.032). The 
number of patients with no or milder 
symptoms was 73 of 111 (66%) in the 
allergic group and 43 of 67 (64%) in 
the non-allergic group (difference 
between the proportions 0.02, 95% CI 
-0.13 to 0.16, χ² = 0.05, P = 0.83). 
The series of 108 patients studied 
in 1993–94 included 24 (49%) of the 
subjects who reported no symptoms 
and 84 (64%) of the subjects who 
stated that they still had symptoms. 
The difference between the proportions 
was 0.15 (95% CI -0.01 to 0.31, χ² = 
3.41, P = 0.065). 
The overall change in symptom 
severity was assessed also in con-
nection with the clinical follow-up visit 
(II, IV). In this evaluation, the 
proportion of symptom-free patients 
was 8 in the whole series of 108 (7%). 
Grouped together, the patients whose 
rhinitis was in remission or had 
become milder were as many as 73 
(68%, 95% CI 58%–76%). Table 5 
shows the distribution of patients by 
changes in symptom severity. Assessed 
on the basis of the prick-test results in 
1993–94, remission had occurred in 6 
of 72 (8%) in the prick-test positive 
and in 2 of 34 (6%) in the prick-test 
negative group. The number of patients 
with no or milder symptoms was 47 of 
72 (65%) in the prick-test positive and 
25 of 34 (74%) in the prick-test 
negative group (difference between the 
proportions 0.08, 95% CI -0.10 to 0.27, 
χ² = 0.72, P = 0.40). Grouped ac-
cording to the results of allergen 
provocation, 39 patients of 60 (65%) in 
the challenge-positive group and 28 
patients of 39 (72%) in the challenge-
negative group had no or milder 
symptoms of rhinitis (difference 
between the proportions 0.07, 95% CI 
-0.12 to 0.25, χ² = 0.50, P = 0.48). 
Age and gender showed no asso-
ciation with the change in rhinitis 
symptom severity. The mean age was 
50.7 (SD 11.7) years in the group with 
favourable changes and 50.6 (SD 11.8) 
Table 5. Changes in rhinitis symptoms in 180 patients participating in a questionnaire study (I) 18 
years after initial examinations and diagnosis and in 108 patients participating in a clinical study after 
a follow-up period of 23 years 
Change in symptom severity No. of patients, 
18 years’ follow-up 
(N=180) 
No. of patients, 
23 years’ follow-up 
(N=108) 
Disappeared or less severe 116 (64%) 73 (68%) 
Equally severe 42 (23%) 19 (18%) 
More severe 20 (11%) 16 (15%) 
Symptomatic, but change not reported 2 (1%)  
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years in the group with equally or more 
severe symptoms (difference between 
the means 0.2 years, 95% CI –4.7 to 
5.0 years, t = 0.062, P = 0.95). Forty-
three of 61 (70%) female and 30 of 47 
(64%) male patients reported that their 
rhinitis symptoms had ceased or 
become milder (difference between the 
proportions 0.07, 95% CI -0.11 to 0.25, 
χ² = 0.54, P = 0.46) (Simola M et al., 
unpublished data). 
Smoking was significantly 
associated with the development of 
rhinitis symptoms. Only 9 of 21 (43%) 
smokers reported that symptoms had 
disappeared or become milder, while 
their number was 64 (74%) in the 
group of 87 non-smokers or ex-
smokers (difference between the 
proportions 0.31, 95% CI 0.08 to 0.54, 
χ² = 7.28, P = 0.0070). When history 
of smoking was used as a criterion, the 
difference was smaller. Symptoms had 
disappeared or become milder in 34 of 
54 (63%) subjects with a history of 
smoking and in 39 of 54 (72%) 
subjects who had never smoked 
(difference between the proportions 
0.09, 95% CI -0.08 to 0.27, χ² = 1.06, 
P = 0.30) (Simola M et al., 
unpublished data). 
Table 6. Changes in skin-test positivity of 106 rhinitis patients during the follow-up period of 23 years. 







Pollen 59/100 (59%) 63/100 (63%) 0.04 -0.05 to 0.11 
House dust* 56/94 (60%) 15/94 (16%) -0.44 -0.35 to -0.46 
House dust mite 6/69 (9%) 12/69 (17%) 0.09 -0.02 to 0.14 
Animal dander 23/82 (28%) 34/82 (41%) 0.13 -0.01 to 0.25 
* House dust mite tested instead of house dust in the follow-up study 
 
Allergy tests (studies II, 
III and IV) 
Seventy-two (68%, 95% CI 58%–77%) 
of 106 analysed patients showed at 
least one positive reaction in skin prick 
tests (study II). The number of positive 
tests per patient ranged from 1 to 17 
(median 8, quartiles 3 and 11, mode 
11). The proportion of skin-test 
positive patients had decreased 
significantly, as compared with the 
initial study, where the percentage was 
78. The difference between the 
proportions was 0.10 (95% CI 0.02–
0.16, χ² = 5.26, P = 0.022, McNemar’s 
test). Different allergen groups are 
analysed for proportions of skin-test 
positive patients in Table 6. Though 
the proportions of positive reactions to 
pollen, house dust mite and other 
animal allergens remained relatively 
stable, there were several individual 
patients in whom the reactions had 
converted from negative to positive or 
reverted from positive to negative: ten 
conversions and six reversions in 
pollen allergen tests, eight conversions 
and two reversions in house dust mite 
allergen tests, 21 conversions and ten 
reversions in animal allergen tests. All 
prick-test positive patients in the 
follow-up study had a positive reaction 
to pollens, house dust mite or animal 
dander, i.e. no patient had positive 
reactions exclusively to the four 
allergens that were added to the test 
series during the study. 
There was a significant downward 
trend in prick-test positivity with 
advancing age both in the whole series 
and in the patient group with initially 
confirmed allergy. In the whole series, 
Results 
 
the patients with at least one positive 
prick-test reaction in the present study 
were significantly younger (mean age 
47.1, SD 10.8 years) than the prick-test 
negative patients (mean age 58.0, SD 
9.9 years, difference between the 
means 10.9, 95% CI 6.6–15.2 years, t 
= 4.98, P < 0.0001). In the group of 
patients with initially confirmed nasal 
allergy, the mean ages were 46.3 (SD 
10.6) years in the prick-test positive 
and 55.5 (SD 9.8) years in the prick-
test negative group (the difference 
between the means 9.2, 95% CI 2.8–
15.5 years, t = 2.88, P = 0.0053). The 
numbers of prick-test positive and 
prick-test negative patients are 
presented by age group in Figure 1. 
No association could be seen 
between skin-test reactivity and 
duration of rhinitis symptoms. The 
average duration was 30.7 (SD 6.7) 
years in the prick-test positive and 32.5 
(SD 11.4) years in the prick-test 
negative group. The difference was not 
significant (U = 1066.5, P = 0.97, 
Mann–Whitney test). Ninety-eight 
patients (93%) reported that they still 
had symptoms of rhinitis, and eight 
(8%) that symptoms no longer 
occurred. Of those who still had 
symptoms, 64 now reported milder, 18 
equally severe, and 16 more severe 
symptoms. There was no difference in 
the proportions of prick-test positive 
patients between the groups with 
different symptom changes, the 
percentages varying between 64 and 75 
(χ²trend = 0.38, P = 0.54) in the whole 
series and between 77 and 100 (χ²trend 
= 2.24, P = 0.13) in the patient group 
with initially verified allergy. 
A similar significant downward 
trend was apparent in the evaluation of 
the results of nasal allergen challenge 
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Figure 1. Age-related prick test reactivity in the follow-up study. Numbers and percentages of prick-
test positive and negative subjects distributed by age in the whole series (χ²trend = 16.79, P < 0.0001) 
and in the group of patients with initially verified allergy (χ²trend = 8.86, P = 0.0029). 
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the mean ages of the challenge-positive 
and challenge-negative patients were 
46.1 (SD 10.8) and 58.0 (SD 9.6) 
years, respectively, (difference 
between the means 11.9, 95% CI 7.6–
16.1 years, t = 5.57, P < 0.0001), while 
the mean ages of these patients were 
45.2 (SD 10.3) and 57.0 (SD 9.6) years 
in the group with initially confirmed 
allergy (difference between the means 
11.9, 95% CI 6.0–17.7 years, t = 4.07, 
P = 0.0001). The proportions of 
challenge-positive patients are depicted 
by age group in Figure 2. 
Forty-two of 75 patients with ini-
tially confirmed allergy had received 
allergen immunotherapy. Thirty-eight 
(90%) of them were still prick-test 
positive, whereas 22 of 30 (73%) 
tested in the group without immuno-
therapy showed a positive prick-test 
result. The difference between the 
proportions was 0.17 (95% CI -0.01 to 
0.35, P = 0.11, Fisher’s exact test). 
One patient was not tested because of 
early withdrawal and two patients 
could not give reliable information on 
immunotherapy. A similar result was 
obtained for nasal challenge: the 
challenge was positive in 32 of 39 
(82%) challenged patients who had 
received immunotherapy and in 18 of 
26 (69%) who had not (difference 
between the proportions 0.13, 95% CI 
-0.09 to 0.34, P = 0.25, Fisher’s exact 
test). 
Altogether 78 patients were both 
prick-tested and challenged with 
allergen in the follow-up study. In 58, 
both tests indicated allergy and in 10, 
both tests were negative. Two prick-
test negative patients showed a positive 
challenge reaction and eight prick-test 
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Figure 2. Nasal allergen provocation results in relation to age in the follow-up study. Numbers and 
percentages of challenge positive and negative subjects distributed by age in the whole series (χ²trend = 




the challenge. The value of kappa was 
0.59 (95% CI 0.35–0.83), which, 
according to Altman (1994b), reflects 
moderate agreement. 
Nasal histamine 
provocation (study IV) 
To compare histamine reactivity in 
different groups, the 73 patients were 
grouped according to the results of 
prick tests and nasal allergen provo-
cation in conjunction with study II. 
Allergic rhinitis had been confirmed in 
all patients in the initial study. Sixty of 
73 patients (82%) now showed at least 
one positive prick-test reaction and 50 
of 66 (76%) had a positive response to 
allergen provocation. 
Seven patients with initially veri-
fied allergy were excluded from the 
allergen challenge analysis: three 
refused and for four the appropriate 
allergens for provocation were not 
available. 
Prick-test negative and prick-test 
positive groups had nearly identical 
responses to histamine challenge, as 
assessed with the concentration which 
induced an average increase of at least 
one point in nasal secretion or at least 
five sneezes (variable 1). The median 
end point concentration was 0.1% in 
both groups (U = 375.5, P = 0.83). In 
the comparison of the challenge-
negative and the challenge-positive 
groups, the median end point concen-
tration was 0.05% in the former and 
0.025% in the latter group. This 
difference was not significant (U = 
309, P = 0.16). 
The analysis of variance for re-
peated measurements indicated that 
prick-test positive patients reacted 
more strongly to increasing histamine 
concentrations than those whose skin-
test reactivity had ceased during the 
follow-up period. This type of inter-
action was seen both with regard to 
sneezing and discharge (variable 2) 
(F4,280 = 3.38, P = 0.01) and with 
regard to sneezing, discharge and 
swelling (variable 3) (F4,280 = 3.28, P = 
0.012) but not to TNR (variable 4), 
which gradually became 3.7-fold in the 
prick-test negative and 4.1-fold in the 
prick-test positive group (F4,268 = 0.07, 
P = 1). Also when the series of vari-
able 2 were analysed in the groups 
with positive and negative nasal 
provocation results, histamine elicited 
stronger reactions in the patients with 
verified nasal allergy than in the 
challenge-negative group (F4,256 = 
2.67, P = 0.033). This was also true for 
the series of variable 3 (F4,256 = 2.76, P 
= 0.028) but not for TNR, which 
progressively became 3.4-fold in the 
challenge-negative and 4.3-fold in the 
challenge-positive group (F4,248 = 0.47, 
P = 0.76). 
The sizes of weals elicited by the 
histamine control in the skin-prick test 
correlated poorly with the nasal 
response to histamine. Spearman’s 
rank order coefficients between the 
histamine control weal and variables 
1–4 were -0.11 to 0.07. 
Sixty-seven patients (92%) 
reported that they still had symptoms 
of rhinitis and six (8%) that symptoms 
no longer occurred. Of those who still 
had symptoms, 44 (60% of the whole 
series) now reported milder, 13 (18%) 
equally severe and 10 (14%) more 
severe symptoms. The groups with 
different symptom severity changes 
did not differ significantly by any 
analysed variable in histamine 
provocation. 
Nasal polyposis 
Thirty-five of 106 analysed prick-
tested patients (33%, 95% CI 24%–
42%) reported that nasal polyps had 
been diagnosed. Seventeen of 35 
Results 
 
(49%) were prick-test positive at the 
follow-up examination, while the 
proportion of prick-test positive 
patients was 55 (77%) among 71 
patients without polyposis. Thus, the 
cumulative prevalence of nasal 
polyposis was 24% in the prick-test 
positive and 53% in the prick-test 
negative group. The difference 
between the proportions was 0.29, 95% 
CI 0.10–0.49, χ² = 8.98, P = 0.0027 
(Simola M et al., unpublished data). 
The occurrence of polyposis was 
not linked with changes in the severity 
of rhinitis symptoms. In the whole 
series, favourable rhinitis changes had 
occurred in 24 (67%) of 36 with a 
history of polyps and in 49 (68%) of 
72 without polyposis (difference 
between the proportions 0.01, 95% CI 
-0.17 to 0.20, χ² = 0.02, P = 0.88) 
(Simola M et al., unpublished data). 
Olfactory threshold 
(study III) 
The olfactory thresholds of 105 rhinitis 
patients and 104 healthy control 
subjects were analysed with forward 
stepwise multiple regression analysis 
with age in years as a continuous 
independent variable, level of smoking 
history as a six-category independent 
variable and history of rhinitis, current 
smoking, gender and history of 
smoking as binary independent vari-
ables. Only age (P < 0.0001) and 
history of rhinitis (P = 0.024) showed 
significant association with olfactory 
threshold in this model with an 
adjusted coefficient of determination 
(R2adj) of 0.202. In the patient data, 
history of polyp operations (P = 
0.0032) and age (P = 0.0015) were 
associated with poorer smell test 
results, whereas prick-test positivity (P 
= 0.017) was associated with better 
smell-test results. 
In the linear regression analysis of 
the control group, the equation of 
olfactory threshold f1(age) as a func-
tion of age (in years) was 
f1(age) = 2.4 + 0.29×(age), 
with a residual standard deviation of 
10.5 and standard error of the 
coefficient of 0.073 (P = 0.0001). 
The equation of the olfactory 
threshold as a function of age fitted to 
the patient data f3(age) was 
f3(age) = -7.6 + 0.62×(age). 
The residual standard deviation was 
17.4 and the standard error of the 
coefficient 0.147 (P = 0.0001). 
The difference between the regres-
sion coefficients was 0.33 (95% CI 
0.02–0.64, t = 2.08, P = 0.039), indi-
cating that the sense of smell 
deteriorated more rapidly in rhinitis 
patients than in the control group. 
There were two (2%) hyposmic 
subjects, i.e. persons whose olfactory 
threshold was higher than the upper 
95% reference limit, in the control 
group and 16 (15%) in the group of 
rhinitis patients. The 0.13 difference in 
the proportions was significant (95% 
CI 0.06–0.21, χ² = 11.77, P = 0.0006). 
The natural logarithms of TNR and 
olfactory threshold showed no signifi-
cant association (Pearson’s correlation 
coefficient -0.15, 95% CI -0.34 to 0.04, 
P = 0.13). 
Olfactory thresholds were lower in 
the group of prick-test positive patients 
than in the prick-test negative group. In 
the analysis of variance with age as a 
covariate, the means were 18.9 and 
33.9 and the adjusted means 21.2 and 
31.5 logarithmic units, respectively. 
The difference between the groups was 
significant (P = 0.0096). There was a 
significant intergroup difference (P = 
0.0097) also between different types of 
rhinitis (seasonal allergic, n=28, peren-
nial allergic, n=36, non-allergic, n=33, 
according to skin-test results). The 
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average olfactory thresholds were 17.5, 
18.6, and 35.0, and the age-adjusted 
means 20.4, 18.7 and 32.0 units, 
respectively. Non-allergic patients 
demonstrated significantly higher 
thresholds than seasonal (P = 0.0006) 
and perennial (P = 0.0006) allergic 
patients but no difference could be 
found between the types of allergic 
rhinitis (P = 0.97) (Scheffé test). 
Nasal polyposis severe enough to 
require polypectomy or ethmoid-
ectomy was associated with impaired 
sense of smell. Thirty patients (29%) 
reported that they had undergone 
surgery for nasal polyps. Ten (33%) of 
them were hyposmic, whereas only 6 
(8%) of the 75 patients with no polyp 
operations had olfactory thresholds 
above the reference interval (difference 
between the proportions 0.25, 95% CI 
0.07–0.43, Yates-corrected χ²c = 8.78, 
P = 0.0031). Among the patients with 
and without prior maxillary sinus 
operations, the proportions of 
hyposmic subjects were 3 (27%) of 11 
and 12 of 87 (14%), respectively 
(difference between the proportions 
0.13, 95% CI -0.14 to 0.41, P = 0.37, 
Fisher’s exact test). 
The patients’ subjective view of 
their olfactory perception was in 
accordance with the results of the 
measurements. The mean olfactory 
threshold was 35.3 (SD 21.9) units in 
the group of 38 who reported deterio-
ration of the sense of smell and 17.2 
(SD 13.0) units in the 64 who thought 
they had normal sense of smell 
(difference between the means 18.1, 
95% CI 11.2–24.9 units, t = 5.24, P < 




The patients in this study represent a 
small proportion of the rhinitis patients 
included in the initial study at our 
clinic two decades earlier. While a 
long observation period is likely to 
give a more accurate picture of 
changes, certain disadvantages become 
apparent. The number of patients in the 
first survey was 770, but only 23% of 
them took part in the questionnaire 
study (I) 18 years later, and 14% in the 
clinical follow-up studies (II, III and 
IV). Many patients had died or been 
disabled due to ageing or diseases, but 
presumably the main reason for lack of 
compliance was moving to another 
area or unwillingness to be re-
investigated. It is plausible that pa-
tients who have no or very mild 
symptoms are more reluctant to 
participate. If this is the case, remis-
sion or improvement is in fact more 
frequent than our results suggest. This 
assumption is also supported by the 
difference in compliance between 
symptomfree and symptomatic sub-
jects who had participated in our first 
questionnaire study; refusal to take part 
in the clinical follow-up investigations 
was more frequent among symptom-
free subjects than among those who 
still had symptoms of rhinitis. 
Patient history 
Two questionnaires were used to 
collect information on the development 
of rhinitis symptoms and other relevant 
data in the patient history. As many as 
66–68% of the patients stated that their 
rhinitis symptoms had either ceased or 
become milder. The percentage is 
somewhat higher than the 56% re-
ported by Lehtonen and Haahtela 
(1988) after seven years’ follow-up of 
adult patients, and clearly higher than 
the 38% reported by Smith (1971) in a 
group of children followed for five 
years. It is understandable that many 
subjects have difficulties in remem-
bering details of their symptoms over a 
period of 20 years and there are 
obvious sources of error in using a 
questionnaire to collect information. 
This was particularly evident in the 
answers concerning appearance of 
asthmatic symptoms. To avoid errors 
due to the patients’ misunderstanding 
of their asthma-like symptoms, we 
used a rather strict ”official” criterion 
of asthma in the analysis of the smell-
test results (III), i.e. entitlement to 
special drug reimbursement for treat-
ment of asthma. The criterion of 
polyposis in study III, i.e. history of 
operations for nasal polyps, was also 
intentionally strict. Anamnestic data 
revealed history of polyps in a few 
more patients and it is possible that 
nasal endoscopy or computed tomogra-
phy would have revealed even more 
polypoid changes. These methods were 
not available at the time of the initial 
study in 1969–1972 and were, there-
fore, not included in the follow-up 
study. 
We tried to keep the main questions 
about rhinitis symptoms as simple as 
possible and asked the patient, if 
symptoms still occurred and if so, 
whether symptoms were now milder, 
equally or more severe, as compared 
with the symptoms 20 years ago. Even 
this seemed to be difficult for some 
patients, especially if a patient with 
purely seasonal rhinitis answered the 
question out of the season. The 
difference between the proportions of 
symptomfree subjects in the two 
successive questionnaires probably 
Discussion 
 
reflects this difficulty. However, when 
symptomfree patients and patients 
whose symptoms had become milder 
were grouped together, the difference 
between the data was smaller. There 
was an unexpectedly weak association 
between changes in symptom severity 
and other variables such as age, 
gender, prick-test result, allergen 
provocation result, history of nasal 
polyps, history of sinusitis and history 
of asthma. A probable explanation for 
this is that the answer to the question 
about the symptoms only expressed the 
relative change as compared with the 
initial state and not the absolute 
severity of rhinitis. This means that the 
same answer was received from a 
patient in whom a very severe form of 
rhinitis had changed to moderately 
severe and from a patient whose mild 
symptoms had almost disappeared. It is 
also possible that patients with a long-
continuing disease adapt to their 
symptoms, which impairs the sensi-
tivity of a questionnaire study. It is, 
indeed, difficult to obtain reliable 
information on the development of 
symptoms with a questionnaire alone. 
Diary keeping or some other prospec-
tive form of collecting information 
regularly would be a better alternative. 
Clearly, this is not feasible in a 20-year 
follow-up study. 
Allergy tests 
At the time of the initial study between 
1969 and 1972, the skin prick test was 
not a common method in allergy 
diagnostics, but the more sensitive and 
less specific intracutaneous and scratch 
tests were usually used. Today, skin 
prick testing is recommended for 
screening of allergy because of its 
simplicity, rapidity of performance, 
low cost and high specificity (Mygind 
et al. 1996a). In the present follow-up 
study, the standard prick-test series of 
the clinic was used and the selection of 
test allergens was wider than in the 
initial study, especially with regard to 
animal allergens. 
Nasal allergen provocation no 
longer plays a major role in clinical 
management of rhinitis (Mygind et al. 
1996a). In this follow-up study, the 
patients were challenged in order to 
verify present nasal allergy status. The 
bilateral method was chosen to 
minimize the effects of the nasal cycle. 
To include information on all aspects 
of the allergic reaction of the nose in 
the criteria of positivity, a combined 
score of sneezes, changes in nasal 
discharge and mucosal swelling and 
presence of non-nasal symptoms and 
signs was compiled. Nasal resistance 
was measured, but it was used as a 
criterion of positivity only in border-
line cases to distinguish between a 
weak reaction and a negative one. This 
can be seen as an intermediate criterion 
between two extremes, viz. the view 
that rhinomanometry alone can be used 
to determine whether a reaction is 
positive or not (Grobler et al. 1966, 
Bachert et al. 1990, Albegger 1991) 
and the view that the test result can be 
reliably assessed with rhinoscopy 
alone and rhinomanometry need not be 
used at all (Hytönen and Sala 1996). In 
principle, an objective method of 
assessment like rhinomanometry is a 
useful supplement, which can enhance 
the reliability of the interpretation of 
the provocation result. However, a 
satisfactory level of repeatability can 
be reached, only if particular attention 
is directed to the tightness of the parts 
of the equipment and the proper, 
distortion-free position of the mask in 
every mesurement. It is possible that 
the posterior method of measurement 
has less possible sources of error in 
this respect. Unfortunately, it is impos-
sible to perform on many subjects, 
which was the main reason, why 
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anterior rhinomanometry was used in 
this study. 
The criteria of positivity were 
intentionally lax. This can be justified 
in this type of setting, where the main 
purpose was to identify the individuals 
who still had the property to react to 
allergens, even though the clinical 
disease might have disappeared or the 
patient had very mild symptoms. The 
criteria should be more stringent, if the 
purpose was to confirm the diagnosis 
of a present clinical disease, as is the 
case e.g. in the diagnostics of occu-
pational rhinitis, which is currently the 
principal indication for nasal provo-
cation in clinical practice. 
When the patients were first 
classified as allergic or non-allergic in 
1969–72, rather strict criteria were 
used. For the diagnosis of nasal 
allergy, a positive skin test had to be 
confirmed by positive nasal provoca-
tion because of the high sensitivity but 
low specificity of the intracutaneous 
and scratch tests. The initial results and 
those obtained in the present study 
may thus be considered comparable. 
However, it must be borne in mind that 
the composition and quality of the old 
house dust extract does not correspond 
with the modern concept of a stand-
ardized allergen extract and cannot be 
compared to the house dust mite 
allergen extract which was used in the 
follow-up study. Therefore, the com-
parison of the old and new house dust 
and house dust mite provocations 
revealed some differences that 
probably do not reflect a true change in 
the allergy status of the patients. 
Allergic reactivity showed a clear 
downward trend in the older subjects. 
This is consistent with earlier results 
(Barbee et al. 1987). In the skin-test 
responses, significantly more changes 
had occurred from positive to negative 
than vice versa. The main reason for 
the difference seemed to be the large 
number of probably non-specific house 
dust reactions. When these reactions 
were excluded from the comparison, 
the difference essentially disappeared. 
In the majority of patients the condi-
tion was unchanged. A more detailed 
comparison of different allergen 
groups revealed more changes, how-
ever, indicating that while reactivity to 
some allergens decreased, the patients 
developed new reactions. New aller-
gies were found especially for animal 
danders. 
Barbee and co-workers (1987) have 
reported a higher frequency of skin-test 
reactivity among ex-smokers than 
among smokers or non-smokers. In our 
series, no significant differences could 
be seen between these groups. It is 
possible that the long follow-up period 
in itself had such a strong impact on 
skin-test reactivity that a minor 
difference between various smoking 
groups was not revealed. 
At the time of the initial study, 
immunotherapy was a fairly common 
form of allergy treatment. Our data did 
not show any benefit of allergen 
immunotherapy in the long-term 
results. However, no definite conclu-
sions can be drawn from this, because 
our patients were not included in a 
randomized trial, but were selected for 
immunotherapy, when there were 
adequate indications. Moreover, the 
extracts which were used at the time 
cannot be compared with today’s 
specific immunotherapy preparations. 
Nasal histamine 
provocation 
There are no accepted standards for the 
procedure of nasal allergen provo-
cation, only some loose recommen-
dations. As regards nasal histamine 
provocation, there is hardly any 
uniformity at all but a variety of 
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methods are used. In study IV, we used 
a modification of the procedure 
described by Gerth van Wijk and 
Dieges (1987). Histamine phosphate 
was chosen as the test substance, 
because it induces changes in nasal 
mucosal thickness and glandular 
function and it is also an irritative 
agent. Histamine phosphate is widely 
used as a test substance in bronchial 
challenge, from which the fourfold 
increase in the concentration of the 
successive solutions was adopted. 
A combined score for changes in 
nasal discharge and irritation was used 
as a variable, because it has proved 
useful in discriminating between 
rhinitis patients and control subjects in 
nasal histamine challenge (Gerth van 
Wijk and Dieges 1987). This variable 
did not show differences in our study, 
where fourfold histamine concentration 
steps were used instead of the double 
concentrations of the original report. 
More variables were created to make 
the analysis more sensitive. Thus, 
assessment of variables 2 (sneezing 
and discharge) and 3 (sneezing, 
discharge and swelling) with analysis 
of variance for repeated measurements 
showed significant differences both 
between the groups of prick-test 
positive and prick-test negative 
patients and between the groups of 
challenge-positive and challenge-
negative patients. In the majority of 
our patients, severity of allergic 
symptoms and allergy test reactivity 
had changed considerably in the 20 
years since the verification of allergic 
rhinitis (II). The results of the 
histamine provocations suggest that 
there is a link between nasal histamine 
sensitivity and the development of 
sensitivity to allergens as revealed by 
skin tests and nasal provocation. The 
differences became apparent only at 
the strongest concentrations, and even 
then the test was only capable of 
differentiating between the groups, not 
to predict the status of a single patient. 
As described in an earlier study (Gerth 
van Wijk and Dieges 1987), TNR was 
less sensitive than the other variables 
in detecting differences between the 
groups of subjects. 
Several factors may account for the 
association between changes in allergy 
test reactivity and nasal histamine 
sensitivity in patients with long-
standing verified allergic rhinitis. A 
decrease in nasal histamine sensitivity 
could be conveniently explained by a 
concomitant decrease in histamine 
sensitivity of the skin, but the poor 
correlation between histamine-induced 
changes in nasal status and skin weal 
suggests that this explanation is not 
valid. In their study, Gerth van Wijk 
and Dieges (1987) compared nasal 
reactivity of healthy subjects and 
patients with allergic rhinitis and 
suggested that the difference in 
reactivity might be explained by 
increased permeability of the diseased 
mucosa, which made possible a greater 
penetration of the test agents. They 
also presented two other hypotheses, 
viz., an elevated reflex-mediated ac-
tivity in allergic patients and hyper-
reactivity to changes in glands and 
vessels, which both might, in fact, also 
reflect the altered permeability of the 
mucosa. The assumption that mucosal 
permeability is enhanced in allergic 
rhinitis patients has also been made by 
earlier investigators (Salvaggio et al. 
1964, Inagaki et al. 1985). If this were 
true, recovery of normal permeability 
would lead to a simultaneous decrease 
in nasal histamine and allergen sen-
sitivity. Decline in skin reactivity 
would then reflect a weakening of 
allergen-induced reactions in the 
course of time. Symptom severity 
should decrease accordingly, but in our 
series this did not always occur. 
Moreover, later studies have shown 
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contradictory results suggesting that 
mucosal absorption is in fact reduced 
in patients with allergic rhinitis (Greiff 
et al. 1993, Greiff et al. 1997). Thus, 
other explanations must exist, e.g. a 
functional disturbance of the nasal 
epithelial lining, which may result in 
increased exposure of the tissue, 
especially the sensory nerves, to 
exogenous stimuli and agents 
(Andersson and Mygind 1995). 
Many studies have been done in the 
hope of developing nasal histamine 
provocation into a routine diagnostic 
procedure for evaluating rhinitis pa-
tients. Ours was not an exception but 
we did not succeed in defining useful 
simple variables for mapping nasal 
hyperreactivity. At present, nasal 
histamine provocation remains a 
research tool for comparisons between 
patient groups or between findings at 
different points of time but of minor 
importance in daily clinical work. 
Olfactory threshold 
Though disorders of olfaction are 
common clinical problems, they are 
usually poorly identified and there is 
no specific medical specialty to 
promote their evaluation or treatment 
(Henkin 1995). Hyposmia is often 
reported as a common feature in 
association with long-standing rhinitis, 
but there are few reports in which the 
sense of smell has been quantitatively 
assessed in rhinitis patients. Moreover, 
the influence of age has, as a rule, been 
neglected in this context. Study III 
describes the age-adjusted reference 
interval of olfactory threshold, as 
measured with a commercially avail-
able method. Also when age-related 
changes are allowed for, the results of 
the study confirm that rhinitis impairs 
the sense of smell. 
The proportion of hyposmic sub-
jects was larger in the rhinitis group 
than in the control group, also when 
the impact of age was taken into 
consideration. Furthermore, the regres-
sion analysis results indicated that the 
sense of smell deteriorated more 
rapidly in rhinitis patients than in 
persons with healthy noses. One would 
expect that the longer the patient 
suffers from rhinitis, the poorer the 
sense of smell. However, we could not 
find any significant direct association 
between the duration of rhinitis and the 
olfactory threshold. This might be 
explained by the fact that the series of 
patients in this study was highly 
selected and all had had nasal disease 
for more than 20 years, i.e. such a long 
time that minor differences in the 
duration may not have had a 
demonstrable influence on olfaction. In 
a non-selected sample of rhinitis 
patients the result could be quite 
different. Olfactory threshold and nasal 
patency could be expected to be 
closely associated with one another. 
Many studies, including the present 
one, have shown that this is not the 
case (Eccles et al. 1989, Cowart et al. 
1993, Lane et al. 1996). Nasal 
resistance, as measured by rhino-
manometry, reflects the air flow 
through the nose, but, except for the 
cases with total obstruction, not the air 
flow to the locus of the olfactory 
epithelium. Probably, olfactory thresh-
old is related to circumstances in the 
upper parts of the nasal cavities rather 
than the size of the lower turbinates, 
which mostly regulates the degree of 
nasal obstruction. 
The olfactory thresholds of prick-
test positive patients were lower than 
those of patients with non-allergic 
rhinitis. This result suggests that non-
allergic disease could be more 
damaging to the sense of smell than 
allergic rhinitis. Nasal polyposis 
usually indicates severe chronic rhi-
nitis, and it is not surprising that a 
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disease requiring polyp operations had 
led to higher olfactory thresholds than 
other types of rhinitis. A history of 
maxillary sinus operations had less 
impact on olfaction. There may be 
several reasons for this difference. 
Firstly, chronic maxillary sinusitis is 
usually not as persistent a disease as 
polyposis and, secondly, the diseased 
mucosa lies farther from the olfactory 
epithelium than the affected mucosa in 
ethmoidal polyposis and surgery 
involves less manipulation of the 
region of the olfactory epithelium. 
 CONCLUSION AND SUMMARY 
The main purpose of this study was to 
obtain information about changes in 
rhinitis symptoms and allergy test 
results over a long period of time and 
to relate the changes to the results of 
smell tests and nasal histamine 
provocation. 
The downward trend in the present 
results indicates that symptoms of 
rhinitis tend to disappear or become 
less severe with the passage of time. 
The proportion of patients whose 
symptoms had either disappeared or 
become milder was 64% after 18 
years’ and 68% after 23 years’ follow-
up. The change in symptom severity 
was not associated with age or gender. 
During the follow-up period, the 
proportion of patients with positive 
skin tests decreased from 78% to 68%. 
However, if the patients with a positive 
reaction to only house dust in the 
initial study were excluded, the 
decrease essentially disappeared. The 
detailed records of reactions to 
different allergens, on the other hand, 
showed that individual reactivity to 
allergens had changed either from 
negative to positive or vice versa in 
several patients. Prick-test positivity 
tended to decrease with advancing age, 
but there was no association between 
skin-test reactivity and duration of 
rhinitis symptoms or between skin-test 
reactivity and changes in rhinitis 
symptom severity. 
According to the smell test results, 
ageing is the most important factor that 
determines the changes in the sense of 
smell but even when age-related 
changes are taken into account, also 
chronic rhinitis impairs the sense of 
smell. This was seen both in the result 
of the regression analysis, indicating 
that the sense of smell deteriorated 
more rapidly in rhinitis patients than in 
subjects without rhinitis, and in the 
comparison of the proportions of 
hyposmic subjects, the proportion 
being greater in the group of rhinitis 
patients than in the group of healthy 
persons. Prick-test positive patients 
had lower olfactory thresholds than 
patients with non-allergic rhinitis. 
Nasal polyposis requiring polyp 
operations was associated with higher 
olfactory thresholds than other types of 
rhinitis, whereas a history of maxillary 
sinus operations had less impact on 
olfaction. In this study, duration of 
rhinitis, gender, smoking status and 
NAR showed no association with the 
olfactory threshold. 
Long-term development of skin 
reactivity to allergens was linked with 
nasal sensitivity to histamine, but 
neither skin reactivity to allergens nor 
nasal sensitivity to histamine was 
associated with a change in nasal 
symptom severity. Thus, an association 
between the results of allergy tests and 
nasal histamine provocation can be 
apparent in a comparison of skin-test 
positive and negative patients, but 
overlapping between the patient groups 
is considerable and histamine 
provocation is not suitable as a 
diagnostic method to examine 
individual patients. 
In clinical work, the physician 
often sees a patient who wants to 
know, how his or her rhinitis is going 
to develop in the long run. The 
conclusion which can be drawn from 
this study is that we can encourage our 
patients with the knowledge that their 
rhinitis symptoms are likely to get 
milder and the allergic reactivity will 
probably decrease, but the changes 
may need years or decades to emerge. 
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